RV, R., NG, M., AM, M., SN, L., N, M. A., LA, J., . . . RA, S. (2026). Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma. Annals of oncology : official journal of the European Society for Medical Oncology, 37(2), 206. https://doi.org/10.1016/j.annonc.2025.10.1237
Chicago Style (17th ed.) CitationRV, Rawson, et al. "Pathological Response Calculation Assessment Remains Accurate with Reduced Tumor Bed Examination After Neoadjuvant Immunotherapy in Clinically Detectable Stage III Melanoma." Annals of Oncology : Official Journal of the European Society for Medical Oncology 37, no. 2 (2026): 206. https://doi.org/10.1016/j.annonc.2025.10.1237.
MLA (9th ed.) CitationRV, Rawson, et al. "Pathological Response Calculation Assessment Remains Accurate with Reduced Tumor Bed Examination After Neoadjuvant Immunotherapy in Clinically Detectable Stage III Melanoma." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 37, no. 2, 2026, p. 206, https://doi.org/10.1016/j.annonc.2025.10.1237.
